SAB Biotherapeutics Inc. (SABS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    SAB Biotherapeutics Inc.

    NASDAQ: SABS · Real-Time Price · USD
    2.01
    -0.09 (-4.29%)
    At close: Sep 26, 2025, 3:59 PM
    2.06
    2.49%
    After-hours: Sep 26, 2025, 06:01 PM EDT

    SAB Biotherapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 8.9M 56.57M 15.05M 33.21M
    Short-Term Investments
    		 11.86M n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 482.1K 350.23K 467.69K n/a
    Receivables
    		 54.95K n/a 5.56M 8.01M
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 2.98M n/a n/a 6.34M
    Total Current Assets
    		 23.79M 58.91M 22.1M 50.19M
    Property-Plant & Equipment
    		 19.92M 24.68M 28.34M 30.95M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 20.4M 25.03M 28.81M 30.95M
    Total Assets
    		 44.2M 83.94M 50.9M 79.37M
    Account Payables
    		 1.69M 945.93K 3.68M 4.46M
    Deferred Revenue
    		 n/a 1.32M n/a 100K
    Short-Term Debt
    		 811.84K 1.05M 772.66K 1.8M
    Other Current Liabilities
    		 5.47M 4.49M 8.1M 13.99M
    Total Current Liabilities
    		 7.98M 10.81M 14.99M 24.68M
    Long-Term Debt
    		 n/a n/a 541.64K n/a
    Other Long-Term Liabilities
    		 6.39M 11.77M 320.93K 10.72M
    Total Long-Term Liabilities
    		 10.25M 15.83M 4.85M 16.14M
    Total Liabilities
    		 18.23M 26.64M 19.85M 40.82M
    Total Debt
    		 4.67M 5.91M 5.93M 8.52M
    Book Value
    		 25.97M 57.3M 31.06M 38.55M
    Book Value Per Share
    		 2.80 10.38 7.14 8.87
    Common Stock
    		 935.00 929.00 5.09K 4.35K
    Retained Earnings
    		 -124.17M -90.06M -47.87M -29.13M
    Comprehensive Income
    		 -135.41K 26.42K n/a n/a
    Shareholders Equity
    		 25.97M 57.3M 31.06M 38.55M
    Total Investments
    		 11.86M n/a n/a n/a

    Add to Watchlist